GSK Investigational Site

Graz-Eggenberg A-8020

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease

Studies at this site

• Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers — Stopped early
• Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease — Completed